Pharmaceutical products

Tender description

NHS framework for the Midlands and East, Branded Medicines – Tranche A plus cytokine modulators and other monoclonal antibodies. Offer reference number: CM/PHR/16/5525 CM/PHR/16/5525/01 — NHS framework for the Midlands and East, Branded Medicines – Tranche A, period of framework: 1.3.2020 to 28.2.2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/16/5525/02 — NHS framework for the Midlands and East Branded Medicines — cytokine modulators and other monoclonal antibodies, period of framework: 1.3.2020 to 28.2.2021 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. CM/PHR/16/5525/01 — NHS framework for the Midlands and East, Branded Medicines – Tranche A, period of framework: 1.3.2020 to 28.2.2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Products associated with the lots are listed on document No 05 of the invitation to offer. Each individual National product code (NPC) pack description in each of the regions is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for or be awarded. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. CM/PHR/16/5525/02 — NHS framework for the Midlands and East Branded Medicines — cytokine modulators and other monoclonal antibodies, Period of framework: 1.3.2020 to 28.2.2021 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Products associated with the lots are listed on document No 05 of the invitation to offer. Each individual national product code (NPC) pack description in each of the regions is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for or be awarded. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.